Hims & Hers Health, Inc. (HIMS)
Largest Insider Buys in Sector
HIMS Stock Price History Chart
HIMS Stock Performance
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, …
Insider Activity of Hims & Hers Health, Inc.
Over the last 12 months, insiders at Hims & Hers Health, Inc. have bought $2.08M and sold $135.89M worth of Hims & Hers Health, Inc. stock.
On average, over the past 5 years, insiders at Hims & Hers Health, Inc. have bought $2.25M and sold $65.49M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Payne Christopher D (director) — $3.9M. Manuel Anja (director) — $132,260.
The last purchase of 1,000 shares for transaction amount of $24,500 was made by Manuel Anja (director) on 2024‑11‑14.
List of Insider Buy and Sell Transactions, Hims & Hers Health, Inc.
| 2024-11-19 | Sale | Chief Commercial Officer | 7,500 0.0032% | $22.00 | $165,000 | -0.46% | ||
| 2024-11-18 | Sale | Chief Operating Officer | 58,750 0.027% | $21.04 | $1.24M | +4.06% | ||
| 2024-11-18 | Sale | PAO | 472 0.0002% | $19.42 | $9,166 | +12.77% | ||
| 2024-11-14 | director | 1,000 0.0006% | $24.50 | $24,500 | -21.14% | |||
| 2024-11-13 | Sale | director | 40,000 0.0205% | $29.99 | $1.2M | -21.05% | ||
| 2024-11-13 | Sale | Chief Financial Officer | 142,886 0.073% | $29.93 | $4.28M | -21.05% | ||
| 2024-11-12 | Sale | Chief Legal Officer | 2,338 0.0011% | $26.46 | $61,863 | -13.94% | ||
| 2024-11-12 | director | 4,000 0.0019% | $26.94 | $107,760 | -13.94% | |||
| 2024-11-11 | Sale | Chief Commercial Officer | 7,259 0.0031% | $24.77 | $179,805 | -13.38% | ||
| 2024-11-11 | Sale | Chief Medical Officer | 4,707 0.0023% | $28.24 | $132,926 | -13.38% | ||
| 2024-11-06 | Sale | Chief Medical Officer | 15,000 0.0069% | $22.07 | $331,094 | +1.99% | ||
| 2024-11-05 | Sale | Chief Commercial Officer | 2,054 0.001% | $22.00 | $45,188 | +0.43% | ||
| 2024-11-05 | Sale | Chief Executive Officer | 333,332 0.1589% | $20.76 | $6.92M | +0.43% | ||
| 2024-10-29 | Sale | Chief Legal Officer | 2,339 0.0012% | $23.16 | $54,171 | +5.26% | ||
| 2024-10-25 | Sale | Chief Commercial Officer | 17,304 0.0078% | $22.00 | $380,688 | 0.00% | ||
| 2024-10-21 | Sale | Chief Commercial Officer | 7,500 0.0035% | $22.20 | $166,500 | -0.98% | ||
| 2024-10-16 | Sale | PAO | 471 0.0003% | $22.64 | $10,663 | -0.54% | ||
| 2024-10-15 | Sale | Chief Commercial Officer | 75,493 0.0451% | $22.00 | $1.66M | -2.19% | ||
| 2024-10-15 | Sale | Chief Legal Officer | 2,339 0.0013% | $20.41 | $47,739 | -2.19% | ||
| 2024-10-14 | Sale | Chief Financial Officer | 269,739 0.1487% | $20.31 | $5.48M | +9.07% |
Insider Historical Profitability
| WELLS DAVID B | director | 156036 0.0743% | $25.27 | 4 | 4 | <0.0001% |
| Okupe Oluyemi | Chief Financial Officer | 112186 0.0534% | $25.27 | 1 | 19 | +79.72% |
| Payne Christopher D | director | 110000 0.0524% | $25.27 | 1 | 0 | |
| Dudum Andrew | Chief Executive Officer | 67015 0.0319% | $25.27 | 2 | 35 | <0.0001% |
| Manuel Anja | director | 5000 0.0024% | $25.27 | 2 | 0 |
Institutional Investor Ownership
| The Vanguard Group | $221.38M | 6.66 | 14.31M | +0.97% | +$2.12M | <0.01 | |
| BlackRock | $168.01M | 5.06 | 10.86M | +<0.01% | +$17,156.23 | <0.01 | |
| Marshall Wace | $87.25M | 2.63 | 5.64M | +7.04% | +$5.74M | 0.09 | |
| Institutional Venture Management Xvi Llc | $80.79M | 2.43 | 5.22M | -32.37% | -$38.68M | 93.86 | |
| Institutional Venture Management Xv Llc | $80.79M | 2.43 | 5.22M | -32.37% | -$38.67M | 41.61 |